Johnson & Johnson (JNJ) Assets (2009 - 2026)

Johnson & Johnson has disclosed Assets across 18 years of filings, most recently posting $200.9 billion for Q1 2026.

• Assets for Q1 2026 came in at $200.9 billion, up 3.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $200.9 billion (up 3.73% YoY), and the FY2025 annual result was $199.2 billion, up 10.61% from the prior year.
• Assets came in at $200.9 billion for Q1 2026 at Johnson & Johnson, up from $199.2 billion in the prior quarter.
• In the past five years, Assets ranged from a high of $200.9 billion in Q1 2026 to a low of $166.1 billion in Q4 2023.
• The 5-year median for Assets is $181.6 billion (2022), against an average of $184.1 billion.
• Across the five-year window, Assets retreated 12.25% in 2024 and gained 12.62% in 2025, its largest moves.
• Johnson & Johnson's Assets stood at $175.1 billion in 2022, then retreated by 4.32% to $167.6 billion in 2023, then gained by 7.49% to $180.1 billion in 2024, then gained by 10.61% to $199.2 billion in 2025, then increased by 0.85% to $200.9 billion in 2026.
• The last three Assets figures came in at $200.9 billion (Q1 2026), $199.2 billion (Q4 2025), and $192.8 billion (Q3 2025), per Business Quant data.